{"count": 15, "results": [{"_id": "35506358", "pmid": 35506358, "pmcid": "PMC9677271", "title": "Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma", "journal": "Acta Derm Venereol", "authors": ["Hermans MM", "Breugem CC", "Schappin R", "Jonge Poerink E", "Mendels EJ", "Ragamin A", "Breur JMPJ", "Langeveld HR", "Raphael MF", "De Laat PCJ", "De Wildt SN", "Rietman AB", "Pasmans SGMA", "De Graaf M"], "date": "2022-10-11T00:00:00Z", "doi": "10.2340/actadv.v102.2021", "meta_date_publication": "2022 Oct 11", "meta_volume": "102", "meta_issue": "", "meta_pages": "adv00788", "score": 50246.016, "text_hl": "@DISEASE_271245 @DISEASE_OMIM:271245 @@@Infantile haemangiomas@@@ are common @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@benign tumours@@@ of infancy, which can be treated effectively with beta-blockers such as @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Hermans MM, Breugem CC, Schappin R, Jonge Poerink E, Mendels EJ, Ragamin A, Breur JMPJ, Langeveld HR, Raphael MF, De Laat PCJ, De Wildt SN, Rietman AB, Pasmans SGMA, De Graaf M. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma Acta Derm Venereol. 2022 Oct 11;102():adv00788. PMID: 35506358", "BibTeX": "@article{35506358, title={Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma}, author={Hermans MM and Breugem CC and Schappin R and Jonge Poerink E and Mendels EJ and Ragamin A and Breur JMPJ and Langeveld HR and Raphael MF and De Laat PCJ and De Wildt SN and Rietman AB and Pasmans SGMA and De Graaf M}, journal={Acta Derm Venereol}, volume={102}, pages={adv00788}}"}}, {"_id": "32307329", "pmid": 32307329, "title": "Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population.", "journal": "Urol Oncol", "authors": ["Zahalka AH", "Fram E", "Lin W", "Mohn L", "Frenette PS", "Agalliu I", "Watts KL"], "date": "2020-10-01T00:00:00Z", "doi": "10.1016/j.urolonc.2020.03.024", "meta_date_publication": "2020 Oct", "meta_volume": "38", "meta_issue": "10", "meta_pages": "794.e11-794.e16", "score": 50237.62, "text_hl": "Of beta-blocker types, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ alone was associated with a 38% reduction in odds of incident @DISEASE_Cap_Myopathy @DISEASE_MESH:C579969 @@@CaP@@@ (P= 0.01), with a 40% and 54% reduction in risks of National Comprehensive @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@Cancer@@@ Network intermediate and high-risk @DISEASE_Cap_Myopathy @DISEASE_MESH:C579969 @@@CaP@@@ (P = 0.03 and P = 0.03, respectively) compared to @SPECIES_9606 @@@men@@@ not taking a beta-blocker. ", "citations": {"NLM": "Zahalka AH, Fram E, Lin W, Mohn L, Frenette PS, Agalliu I, Watts KL. Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population. Urol Oncol. 2020 Oct;38(10):794.e11-794.e16. PMID: 32307329", "BibTeX": "@article{32307329, title={Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population.}, author={Zahalka AH and Fram E and Lin W and Mohn L and Frenette PS and Agalliu I and Watts KL}, journal={Urol Oncol}, volume={38}, number={10}, pages={794.e11-794.e16}}"}}, {"_id": "34646131", "pmid": 34646131, "pmcid": "PMC8502859", "title": "beta2-and beta3-Adrenergic Receptors Contribute to Cancer-Evoked Pain in a Mouse Model of Osteosarcoma via Modulation of Neural Macrophages", "journal": "Front Pharmacol", "authors": ["Bruno G", "De Logu F", "Souza Monteiro de Araujo D", "Subbiani A", "Lunardi F", "Rettori S", "Nassini R", "Favre C", "Calvani M"], "date": "2021-09-27T00:00:00Z", "doi": "10.3389/fphar.2021.697912", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "697912", "score": 50232.23, "text_hl": "Conversely, the treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ induced a slight, but not significant, reduction in the @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@tumor@@@ size, denoting a minor role of the @GENE_ADRB1 @GENE_11554 @@@beta1-AR@@@ subtype in controlling @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@tumor@@@ growth (Figure 2A). ", "citations": {"NLM": "Bruno G, De Logu F, Souza Monteiro de Araujo D, Subbiani A, Lunardi F, Rettori S, Nassini R, Favre C, Calvani M. beta2-and beta3-Adrenergic Receptors Contribute to Cancer-Evoked Pain in a Mouse Model of Osteosarcoma via Modulation of Neural Macrophages Front Pharmacol. 2021;12():697912. PMID: 34646131", "BibTeX": "@article{34646131, title={beta2-and beta3-Adrenergic Receptors Contribute to Cancer-Evoked Pain in a Mouse Model of Osteosarcoma via Modulation of Neural Macrophages}, author={Bruno G and De Logu F and Souza Monteiro de Araujo D and Subbiani A and Lunardi F and Rettori S and Nassini R and Favre C and Calvani M}, journal={Front Pharmacol}, volume={12}, pages={697912}}"}}, {"_id": "37991972", "pmid": 37991972, "title": "NITROSAMINE CONTAMINATION WITHIN CARDIAC MULTIMEDICATION - SARTANS (VALSARTAN), CALCIUM CHANNEL BLOCKERS (AMLODIPINE AND NIFEDIPINE), AND ANTIARRHYTHMICS (PROPAFENONE) AS A SIGNIFICANT FACTOR IN THE DEVELOPMENT AND PROGRESSION OF MULTIPLE KERATINOCYTIC CANCERS: ADVANCEMENT ROTATION FLAP FOR KERATOACANTHOMA OF THE UPPER LIP AND UNDERMINING SURGERY FOR BCC OF THE SHOULDER AS AN OPTIMAL DERMATOSURGICAL APPROACH.", "journal": "Georgian Med News", "authors": ["Tchernev G"], "date": "2023-09-01T00:00:00Z", "meta_date_publication": "2023 Sep", "meta_volume": "", "meta_issue": "342", "meta_pages": "152-155", "score": 50224.5, "text_hl": "We report another patient who simultaneously developed 2 @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cutaneous tumors@@@ under potentially/actually @CHEMICAL_Nitrosamines @CHEMICAL_MESH:D009602 @@@nitrosamine@@@ contaminated drugs such as: beta blockers- @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, calcium antagonists- @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@/@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, sartans- valsartan and antiarrhythmics- @CHEMICAL_Propafenone @CHEMICAL_MESH:D011405 @@@propafenone@@@. ", "citations": {"NLM": "Tchernev G. NITROSAMINE CONTAMINATION WITHIN CARDIAC MULTIMEDICATION - SARTANS (VALSARTAN), CALCIUM CHANNEL BLOCKERS (AMLODIPINE AND NIFEDIPINE), AND ANTIARRHYTHMICS (PROPAFENONE) AS A SIGNIFICANT FACTOR IN THE DEVELOPMENT AND PROGRESSION OF MULTIPLE KERATINOCYTIC CANCERS: ADVANCEMENT ROTATION FLAP FOR KERATOACANTHOMA OF THE UPPER LIP AND UNDERMINING SURGERY FOR BCC OF THE SHOULDER AS AN OPTIMAL DERMATOSURGICAL APPROACH. Georgian Med News. 2023 Sep;(342):152-155. PMID: 37991972", "BibTeX": "@article{37991972, title={NITROSAMINE CONTAMINATION WITHIN CARDIAC MULTIMEDICATION - SARTANS (VALSARTAN), CALCIUM CHANNEL BLOCKERS (AMLODIPINE AND NIFEDIPINE), AND ANTIARRHYTHMICS (PROPAFENONE) AS A SIGNIFICANT FACTOR IN THE DEVELOPMENT AND PROGRESSION OF MULTIPLE KERATINOCYTIC CANCERS: ADVANCEMENT ROTATION FLAP FOR KERATOACANTHOMA OF THE UPPER LIP AND UNDERMINING SURGERY FOR BCC OF THE SHOULDER AS AN OPTIMAL DERMATOSURGICAL APPROACH.}, author={Tchernev G}, journal={Georgian Med News}, number={342}, pages={152-155}}"}}, {"_id": "25026350", "pmid": 25026350, "title": "beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration.", "journal": "Pharm Biol", "authors": ["Işeri OD", "Sahin FI", "Terzi YK", "Yurtcu E", "Erdem SR", "Sarialioglu F"], "date": "2014-11-01T00:00:00Z", "doi": "10.3109/13880209.2014.892513", "meta_date_publication": "2014 Nov", "meta_volume": "52", "meta_issue": "11", "meta_pages": "1374-81", "score": 50051.273, "text_hl": "OBJECTIVE: We investigated the efficacy of @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, and @CHEMICAL_ICI_118551 @CHEMICAL_MESH:C026777 @@@ICI118,551@@@ on proliferation, migration, and invasion of non-stimulated @DISEASE_Hereditary_Breast_and_Ovarian_Cancer_Syndrome @DISEASE_MESH:D061325 @@@breast@@@ (@CELLLINE_CVCL:0031 @@@MCF7@@@), @DISEASE_Colonic_Diseases @DISEASE_MESH:D003108 @@@colon@@@ (@CELLLINE_CVCL:0320 @@@HT-29@@@), and hepatocellular (@CELLLINE_CVCL:0027 @@@HepG2@@@) @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ cells. ", "citations": {"NLM": "Işeri OD, Sahin FI, Terzi YK, Yurtcu E, Erdem SR, Sarialioglu F. beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration. Pharm Biol. 2014 Nov;52(11):1374-81. PMID: 25026350", "BibTeX": "@article{25026350, title={beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration.}, author={Işeri OD and Sahin FI and Terzi YK and Yurtcu E and Erdem SR and Sarialioglu F}, journal={Pharm Biol}, volume={52}, number={11}, pages={1374-81}}"}}, {"_id": "12494152", "pmid": 12494152, "title": "[Antihypertensive drugs and malignant neoplasia].", "journal": "Kardiologiia", "authors": ["Preobrazhenskiĭ DV", "Sidorenko BA", "Stetsenko TM", "Kiktev VG"], "date": "2002-01-01T00:00:00Z", "meta_date_publication": "2002", "meta_volume": "42", "meta_issue": "5", "meta_pages": "62-7", "score": 50046.81, "text_hl": "Association between the use of @CHEMICAL_Reserpine @CHEMICAL_MESH:D012110 @@@reserpine@@@ and @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@ in @SPECIES_9606 @@@women@@@, between @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and some types of @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ in elderly @SPECIES_9606 @@@men@@@ also can not be ruled out. ", "citations": {"NLM": "Preobrazhenskiĭ DV, Sidorenko BA, Stetsenko TM, Kiktev VG. [Antihypertensive drugs and malignant neoplasia]. Kardiologiia. 2002;42(5):62-7. PMID: 12494152", "BibTeX": "@article{12494152, title={[Antihypertensive drugs and malignant neoplasia].}, author={Preobrazhenskiĭ DV and Sidorenko BA and Stetsenko TM and Kiktev VG}, journal={Kardiologiia}, volume={42}, number={5}, pages={62-7}}"}}, {"_id": "11465967", "pmid": 11465967, "title": "Antihypertensive therapy and the risk of malignancies.", "journal": "Eur Heart J", "authors": ["Grossman E", "Messerli FH", "Goldbourt U"], "date": "2001-08-01T00:00:00Z", "doi": "10.1053/euhj.2001.2729", "meta_date_publication": "2001 Aug", "meta_volume": "22", "meta_issue": "15", "meta_pages": "1343-52", "score": 50046.44, "text_hl": "The association between @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ death was analysed pooling three randomized controlled studies, including 1879 treated @SPECIES_9606 @@@patients@@@ and 3078 non-treated @SPECIES_9606 @@@patients@@@, yielding a pooled OR of 1.36 (95% CI, 1.02-1.82); however, data from non-randomized studies did not confirm the latter. ", "citations": {"NLM": "Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J. 2001 Aug;22(15):1343-52. PMID: 11465967", "BibTeX": "@article{11465967, title={Antihypertensive therapy and the risk of malignancies.}, author={Grossman E and Messerli FH and Goldbourt U}, journal={Eur Heart J}, volume={22}, number={15}, pages={1343-52}}"}}, {"_id": "7955102", "pmid": 7955102, "title": "Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.", "journal": "Carcinogenesis", "authors": ["Zavanella T", "Radaelli G", "Girotti P", "Arias E", "Ameri L", "Presta M", "Mazzoleni G", "Ragnotti G"], "date": "1994-11-01T00:00:00Z", "doi": "10.1093/carcin/15.11.2531", "meta_date_publication": "1994 Nov", "meta_volume": "15", "meta_issue": "11", "meta_pages": "2531-9", "score": 50046.066, "text_hl": "Evaluation of the @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@tumor@@@-promoting activity of two beta-adrenoreceptor blocking agents, @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, in liver of @CELLLINE_CVCL:V767 @@@Fischer 344@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Zavanella T, Radaelli G, Girotti P, Arias E, Ameri L, Presta M, Mazzoleni G, Ragnotti G. Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats. Carcinogenesis. 1994 Nov;15(11):2531-9. PMID: 7955102", "BibTeX": "@article{7955102, title={Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.}, author={Zavanella T and Radaelli G and Girotti P and Arias E and Ameri L and Presta M and Mazzoleni G and Ragnotti G}, journal={Carcinogenesis}, volume={15}, number={11}, pages={2531-9}}"}}, {"_id": "26728433", "pmid": 26728433, "pmcid": "PMC4700497", "title": "Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells", "journal": "Sci Rep", "authors": ["Talarico G", "Orecchioni S", "Dallaglio K", "Reggiani F", "Mancuso P", "Calleri A", "Gregato G", "Labanca V", "Rossi T", "Noonan DM", "Albini A", "Bertolini F"], "date": "2016-01-05T00:00:00Z", "doi": "10.1038/srep18673", "meta_date_publication": "2016 Jan 5", "meta_volume": "6", "meta_issue": "", "meta_pages": "18673", "score": 50043.12, "text_hl": "Both @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@Aspirin@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@, when added to @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@Metformin@@@, significantly reduced the endothelial cell component of @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@tumor@@@ vessels, whereas pericytes were reduced by the addition of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ but not by the addition of @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@Aspirin@@@. ", "citations": {"NLM": "Talarico G, Orecchioni S, Dallaglio K, Reggiani F, Mancuso P, Calleri A, Gregato G, Labanca V, Rossi T, Noonan DM, Albini A, Bertolini F. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells Sci Rep. 2016 Jan 5;6():18673. PMID: 26728433", "BibTeX": "@article{26728433, title={Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells}, author={Talarico G and Orecchioni S and Dallaglio K and Reggiani F and Mancuso P and Calleri A and Gregato G and Labanca V and Rossi T and Noonan DM and Albini A and Bertolini F}, journal={Sci Rep}, volume={6}, pages={18673}}"}}, {"_id": "10981068", "pmid": 10981068, "title": "Carcinogenicity of cardiovascular drugs.", "journal": "Curr Hypertens Rep", "authors": ["Grossman E", "Messerli FH", "Goldbourt U"], "date": "1999-06-01T00:00:00Z", "doi": "10.1007/s11906-999-0023-8", "meta_date_publication": "1999 Jun", "meta_volume": "1", "meta_issue": "3", "meta_pages": "212-8", "score": 50031.367, "text_hl": "Several prospective studies showed that treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ may increase mortality from @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@malignancy@@@. ", "citations": {"NLM": "Grossman E, Messerli FH, Goldbourt U. Carcinogenicity of cardiovascular drugs. Curr Hypertens Rep. 1999 Jun;1(3):212-8. PMID: 10981068", "BibTeX": "@article{10981068, title={Carcinogenicity of cardiovascular drugs.}, author={Grossman E and Messerli FH and Goldbourt U}, journal={Curr Hypertens Rep}, volume={1}, number={3}, pages={212-8}}"}}]}